SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000882104-13-000037
Filing Date
2013-09-06
Accepted
2013-09-06 16:45:05
Documents
6
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A pdli-20121231x10ka.htm 10-K/A 124848
2 REVENUE INTEREST PURCHASE AGREEMENT BETWEEN THE COMPANY AND AXOGEN, INC. pdli-20121231x10kaex1049.htm EX-10.49 1704336
3 CREDIT AGREEMENT BETWEEN THE COMPANY AND WELLSTAT DIAGNOSTICS, LLC pdli-20121231x10kaex1050.htm EX-10.50 646720
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pdli-20121231x10kaex311.htm EX-31.1 5969
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pdli-20121231x10kaex312.htm EX-31.2 6095
6 pdlilogo.jpg GRAPHIC 7005
  Complete submission text file 0000882104-13-000037.txt   2498843
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19756 | Film No.: 131083485
SIC: 2836 Biological Products, (No Diagnostic Substances)